DURHAM, N.C. (AP) _ Chimerix Inc. (CMRX) on Thursday reported a loss of $16.1 million in its third quarter.
The Durham, North Carolina-based company said it had a loss of 33 cents per share.
The results topped Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 42 cents per share.
The biopharmaceutical company posted revenue of $369,000 in the period, which missed Street forecasts. Four analysts surveyed by Zacks expected $967,000.
The company's shares closed at $3.59. A year ago, they were trading at $4.81.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CMRX at https://www.zacks.com/ap/CMRX